Pacira(PCRX) - 2025 Q2 - Quarterly Results

FOR IMMEDIATE RELEASE NEWS RELEASE -- Conference call today at 4:30 p.m. ET -- BRISBANE, CA, August 5, 2025 - Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported financial results for the second quarter of 2025. Second Quarter 2025 Financial Highlights See "Non-GAAP Financial Information" below. "Throughout the second quarter, we continued to make important progress advancing our 5x ...